Equifax (EFX) Expected to Announce Earnings on Tuesday

Key Points

• Equifax is expected to report Q3 2026 earnings before the market opens on October 20. Analysts forecast earnings of $2.21 per share on $1.69 billion in revenue, compared with company guidance of $2.15–$2.25 EPS.
• In the prior quarter, Equifax earned $2.25 per share, beating estimates by $0.05, while revenue rose 10.6% year over year to $1.70 billion.
• Equifax shares recently traded at $147.34, well below their 52-week high of $238.94. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $206.90, and the company pays a quarterly dividend of $0.56.

Equifax (NYSE:EFX - Get Free Report) is projected to issue its Q3 2026 results before the market opens on Tuesday, October 20th. Analysts expect the company to post earnings of $2.21 per share and revenue of $1.69 billion for the quarter. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Investors can check the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Tuesday, October 20, 2026 at 8:30 AM ET.

Equifax (NYSE:EFX - Get Free Report) last released its earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.05. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. Equifax had a return on equity of 21.61% and a net margin of 10.73%. Equifax's revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company posted $2.00 EPS. On average, analysts expect Equifax to post $8.54 EPS for the current fiscal year and $10.01 EPS for the next fiscal year.

Equifax Stock Up 1.1%

Shares of NYSE:EFX opened at $147.34 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 0.60 and a quick ratio of 0.60. The firm has a market capitalization of $17.31 billion, a PE ratio of 25.89, a price-to-earnings-growth ratio of 1.49 and a beta of 1.35. The firm's 50-day moving average is $169.35 and its two-hundred day moving average is $170.63. Equifax has a 1 year low of $137.01 and a 1 year high of $238.94.

Equifax Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Monday, August 31st were paid a $0.56 dividend. The ex-dividend date of this dividend was Monday, August 31st. This represents a $2.24 annualized dividend and a dividend yield of 1.5%. Equifax's dividend payout ratio (DPR) is presently 39.37%.

Insider Activity

In related news, CEO Mark W. Begor sold 37,791 shares of the company's stock in a transaction that occurred on Friday, July 24th. The shares were sold at an average price of $172.16, for a total transaction of $6,506,098.56. Following the sale, the chief executive officer directly owned 271,890 shares in the company, valued at approximately $46,808,582.40. This represents a 12.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP John Gamble sold 4,500 shares of the company's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $187.96, for a total transaction of $845,820.00. Following the sale, the executive vice president owned 69,055 shares in the company, valued at $12,979,577.80. The trade was a 6.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on EFX. Needham & Company LLC restated a "buy" rating on shares of Equifax in a report on Wednesday, September 16th. Barclays reduced their target price on shares of Equifax from $200.00 to $155.00 and set an "equal weight" rating on the stock in a report on Friday, October 2nd. Royal Bank Of Canada decreased their price target on shares of Equifax from $222.00 to $194.00 and set an "outperform" rating for the company in a research report on Wednesday, July 22nd. BMO Capital Markets dropped their price target on shares of Equifax from $179.00 to $160.00 and set a "market perform" rating for the company in a research note on Wednesday, September 30th. Finally, Rothschild & Co Redburn raised Equifax from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $214.00 to $235.00 in a research report on Friday, August 21st. Fifteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat, Equifax presently has a consensus rating of "Moderate Buy" and an average price target of $206.90.

Equifax Company Profile

Equifax Inc NYSE: EFX is a global data, analytics and technology company that helps businesses, government agencies and consumers make informed decisions about credit, identity, employment and financial risk. The company collects and analyzes information from a broad range of sources to provide insights and decisioning tools for lenders, employers, insurers, telecommunications providers and other organizations.

Its products and services include consumer and commercial credit reports, credit scores, fraud and identity-management solutions, marketing and customer-acquisition analytics, and income and employment verification through The Work Number.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.